WHY ONCOXOME?
WHY EXOSOMES
Our exosomes:
-
Targeted - they naturally target and enter cancer cells from the primary tumor and metastasis. They don’t target or concentrate in any other organ (liver, or kidneys - like the other delivery systems)
-
Non autologous - we can treat different lung cancers as long as they are adenocarcinomas (= 85% of all lung cancer cases)
-
Non toxic
Our exosomes are an ideal non-immunogenic, safe, targeted and efficient vehicle for delivering a therapy payload.
WHY GENE THERAPY?
Gene editing:
-
Is targeted = induces cell death only in targeted cells
-
Knocks out the mutated gene = we do not modify or repair the genome
-
Is the most upstream treatment = inducing rapid cancer cell death
Gene editing therapy is specific, efficacious, easy to use and scalable.
WHY ONCOXOME
- Versatile: adaptable to any cancer type
- Effective: prevents cancer from becoming resistant + induces rapid cancer cell death
- Safe: no cytotoxic material + non toxic exosomes + activity in cancer cells only
- Targeted: selective delivery of therapeutic payload limits patients side effects = reduced costs
Benefits to patients:
-
Improved clinical outcomes
-
Prolonged survival
-
Improved quality of life during cancer treatment